Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024
Kiniksa Pharmaceuticals International (Nasdaq: KNSA) has announced it will host a conference call and live webcast on Tuesday, October 29, 2024, at 8:30 a.m. Eastern Time to report its third quarter 2024 financial results and recent portfolio execution. The live webcast will be accessible through the Investors & Media section of the company's website at www.kiniksa.com.
Individuals interested in participating via telephone can register online to receive dial-in information. A replay of the event will be available on Kiniksa's website within approximately 48 hours after the event.
Kiniksa Pharmaceuticals International (Nasdaq: KNSA) ha annunciato che ospiterà una conference call e una diretta web martedì 29 ottobre 2024, alle 8:30 ora della costa orientale per riportare i suoi risultati finanziari del terzo trimestre 2024 e l'implementazione recente del portafoglio. La diretta web sarà accessibile attraverso la sezione Investitori & Media del sito web dell'azienda all'indirizzo www.kiniksa.com.
Le persone interessate a partecipare telefonicamente possono registrarsi online per ricevere le informazioni di accesso. Una registrazione dell'evento sarà disponibile sul sito di Kiniksa entro circa 48 ore dopo l'evento.
Kiniksa Pharmaceuticals International (Nasdaq: KNSA) ha anunciado que celebrará una conferencia telefónica y una transmisión en vivo el martes 29 de octubre de 2024, a las 8:30 a.m. hora del Este para reportar sus resultados financieros del tercer trimestre de 2024 y la ejecución reciente de su cartera. La transmisión en vivo será accesible a través de la sección de Inversores y Medios en el sitio web de la empresa en www.kiniksa.com.
Las personas interesadas en participar por teléfono pueden registrarse en línea para recibir la información de acceso. Una repetición del evento estará disponible en el sitio web de Kiniksa dentro de aproximadamente 48 horas después del evento.
키니크사 제약 국제 (Nasdaq: KNSA)는 2024년 10월 29일 화요일 오전 8시 30분 동부 표준시에 컨퍼런스 콜 및 라이브 웹캐스트를 개최하여 2024년 3분기 재무 결과 및 최근 포트폴리오 실행에 대해 보고할 것이라고 발표했습니다. 라이브 웹캐스트는 회사 웹사이트 www.kiniksa.com의 투자자 및 미디어 섹션을 통해 실시간으로 접속할 수 있습니다.
전화로 참여하고 싶은 분들은 온라인으로 등록하여 다이얼 인 정보를 받을 수 있습니다. 해당 이벤트의 재생은 이벤트 후 약 48시간 이내에 Kiniksa의 웹사이트에서 제공될 예정입니다.
Kiniksa Pharmaceuticals International (Nasdaq: KNSA) a annoncé qu'elle organisera une conférence téléphonique et un webinaire en direct le mardi 29 octobre 2024 à 8h30, heure de l'Est, pour présenter ses résultats financiers du troisième trimestre 2024 et l'exécution récente de son portefeuille. Le webinaire en direct sera accessible via la section Investisseurs & Médias du site web de l'entreprise à l'adresse www.kiniksa.com.
Les personnes intéressées à participer par téléphone peuvent s'inscrire en ligne pour recevoir les informations de connexion. Un enregistrement de l'événement sera disponible sur le site de Kiniksa dans les 48 heures suivant l'événement.
Kiniksa Pharmaceuticals International (Nasdaq: KNSA) hat angekündigt, dass am Dienstag, den 29. Oktober 2024, um 8:30 Uhr Eastern Time eine Telefonkonferenz und ein Live-Webcast stattfinden werden, um die Finanzergebnisse für das dritte Quartal 2024 und die jüngsten Fortschritte des Portfolios zu berichten. Der Live-Webcast wird über den Bereich Investoren & Medien auf der Unternehmenswebsite unter www.kiniksa.com zugänglich sein.
Interessierte, die telefonisch teilnehmen möchten, können sich online registrieren, um die Einwahlinformationen zu erhalten. Eine Aufzeichnung der Veranstaltung wird innerhalb von etwa 48 Stunden nach der Veranstaltung auf der Website von Kiniksa verfügbar sein.
- None.
- None.
LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 29, 2024 at 8:30 a.m. Eastern Time to report its third quarter 2024 financial results and recent portfolio execution.
A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
ARCALYST® is a registered trademark of Regeneron Pharmaceuticals, Inc.
Every Second Counts! ®
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
FAQ
When will Kiniksa Pharmaceuticals (KNSA) report its Q3 2024 financial results?
What time is Kiniksa Pharmaceuticals' (KNSA) Q3 2024 earnings call?
How can I access Kiniksa Pharmaceuticals' (KNSA) Q3 2024 earnings webcast?
Will there be a replay available for Kiniksa Pharmaceuticals' (KNSA) Q3 2024 earnings call?
